Skip to main content

Breast Cancer

Benefit of Extended Adjuvant Aromatase Inhibition in Breast Cancer Questionable

By Phoebe Starr

March 2017, Vol 7, No 3

Select Ongoing Trials Currently Enrolling Patients with Breast Cancer

Breast Cancer, Clinical Trials Tracker

October 2016, Vol 6, No 10

Addressing Fertility Issues in Younger Women with Breast Cancer

Breast Cancer, Survivorship

December 2015, Vol 5, No 9

Medications Used for the Treatment of Breast Cancer

October 2015, Vol 5, No 7

Clinical Trials Under Way for Patients with Breast Cancer

Breast Cancer, Clinical Trials Tracker

October 2015, Vol 5, No 7

Ibrance (Palbociclib): First CDK4 and CDK6 Inhibitor FDA Approved for the Treatment of Postmenopausal Women with Metastatic Breast Cancer

By Lisa A. Raedler, PhD, RPh

Breast Cancer, Drug Updates

October 2015, Vol 5, No 7

Considerations of a High-Quality Breast Cancer Program

Considerations of a High-Quality Breast Cancer Program

By Linda Bosserman, MD, FACP

Personalized Medicine, Breast Cancer

According to Dr. Bosserman, a high-quality breast cancer program takes into consideration all of a patient’s needs from day 1 through to survivorship. Factors such as early diagnosis and treatment, navigation, care coordination, and survivorship plans must all be part of the process. Read More ›

FDA-Approved Medications Used for the Treatment of Breast Cancer

Breast Cancer, ICD Codes

October 2014, Vol 4, No 6

FDA-Approved Medications Used for the Treatment of Breast Cancer

October 2013, Vol 3, No 6

ASCO Completes Electronic Data Sharing–Standard for Breast Cancer Treatment

June 2013, Vol 3, No 4

Page 16 of 17

13
14
15
16
17